Abstract:Recent evolution in drug repurposing has brought new anticipation, especially in the conflict against neurodegenerative diseases (NDDs). The traditional approach to developing novel drugs for these complex disorders is laborious, time-consuming, and often abortive. However, drug reprofiling which is the implementation of illuminating novel therapeutic applications of existing approved drugs, has shown potential as a promising strategy to accelerate the hunt for therapeutics. The advancement of computational approaches and artificial intelligence has expedited drug repurposing. These progressive technologies have enabled scientists to analyse extensive datasets and predict potential drug-disease interactions. By prospecting into the existing pharmacological knowledge, scientists can recognise potential therapeutic candidates for reprofiling, saving precious time and resources. Preclinical models have also played a pivotal role in this field, confirming the effectiveness and mechanisms of action of repurposed drugs. Several studies have occurred in recent years, including the discovery of available drugs that demonstrate significant protective effects in NDDs, relieve debilitating symptoms, or slow down the progression of the disease. These findings highlight the potential of repurposed drugs to change the landscape of NDD treatment. Here, we present an overview of recent developments and major advances in drug repurposing intending to provide an in-depth analysis of traditional drug discovery and the strategies, approaches and technologies that have contributed to drug repositioning. In addition, this chapter attempts to highlight successful case studies of drug repositioning in various therapeutic areas related to NDDs and explore the clinical trials, challenges and limitations faced by researchers in the field. Finally, the importance of drug repositioning in drug discovery and development and its potential to address discontented medical needs is also highlighted.

Teaching an old dog new tricks: Drug discovery by repositioning natural products and their derivatives

Drug repositioning: Progress and challenges in drug discovery for various diseases

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

The strategies and techniques of drug discovery from natural products

Drug Discovery Prospect from Untapped Species: Indications from Approved Natural Product Drugs

Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases

Some Aspects and Convergence of Human and Veterinary Drug Repositioning

Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

A Pathway Profile-Based Method for Drug Repositioning

Overcoming cancer therapeutic bottleneck by drug repurposing

Lead/Drug Discovery from Natural Resources

Recent Advances in the Synthetic Biology of Natural Drugs

Drug Repurposing: Far Beyond New Targets for Old Drugs

NATURAL PRODUCTS: FROM TRADITIONAL MEDICINE TO LEAD COMPOUNDS FOR DRUG DEVELOPMENT IN THE 21ST CENTURY

Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions

Natural products in drug discovery: advances and opportunities

Recent advances in natural product discovery.

The pharmaceutical industry and natural products: historical status and new trends

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues

Natural products and drug discovery

Drug Repurposing: A Leading Strategy for New Threats and Targets